Related Experiment Video
Updated: Dec 23, 2025

09:26
Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
Published on: June 30, 2023
1.5K
What do we know about the SARS-CoV-2 coronavirus in the environment?
1Dept. Soil Science and Agricultural Chemistry, Engineering Polytechnic School, Campus Univ. Lugo, University Santiago de Compostela, Spain.
The Science of the Total Environment
|April 22, 2020
Summary
Research is needed on SARS-CoV-2 in water and soil via wastewater, and on improving treatment methods. This will help control virus spread in current and future outbreaks.
Area of Science:
- Environmental Science
- Virology
- Public Health
Background:
- The COVID-19 pandemic highlights the potential for SARS-CoV-2 transmission through environmental pathways.
- Wastewater and sewage sludge are key routes for virus dissemination into soil and water.
Purpose of the Study:
- To discuss the necessity of research into SARS-CoV-2 presence and evolution in environmental compartments.
- To evaluate existing wastewater and sludge treatment methods for virus inactivation.
- To explore novel techniques for controlling environmental virus dissemination.
Main Methods:
- Literature review and discussion on environmental virology.
- Analysis of current wastewater and sewage sludge treatment efficacy.
- Conceptual exploration of advanced treatment technologies (sorption, nanotechnology).
Main Results:
- Current research is insufficient regarding SARS-CoV-2 environmental fate and transport.
- Existing treatment methods may not fully eliminate the virus.
- Advanced techniques show promise for enhanced viral control.
Conclusions:
- Further research on SARS-CoV-2 in water and soil is critical.
- Evaluating and developing effective treatment strategies for wastewater and sludge is essential.
- Proactive environmental monitoring and control are necessary for future pandemic preparedness.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
17.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K
Transmission-based Precautions II: Airborne and Protective Environment
1.8K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K
Viral Mutations
39.4K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.4K

